[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"RTI Surgical\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100551166",false,"NCT06456554","Acellular Dermal Matrix Investigation in Breast Reconstruction","ADMIRE","Inclusion Criteria:\n\n* Genetic female\n* Age 22 or older at time of consent\n* Undergoing immediate breast reconstruction\n* 2 stage breast reconstruction using pre pectoral technique\n* Nipple or skin sparing mastectomy\n* Willing and capable of providing informed consent\n* Able to comply with study requirements\n\nExclusion Criteria:\n\n* Planned concurrent reconstruction with pedicled flaps or free tissue\n* Pregnant or breast feeding\n* Investigator has determined tissue is unsuitable for two-stage breast reconstruction\n* History of psychological characteristics that may be incompatible with the surgical procedure and the prosthesis\n* Any serious and\u002For unstable pre-existing medical disorder or other conditions that could interfere with the subject's safety, the informed consent process, or compliance with the study protocol, in the opinion of the investigator\n* Vulnerable subject populations\n* Currently participating in another clinical trial that would have the potential to interfere or conflict with the treatment, follow-up, or objectives of this study\n* Prior history of neoadjuvant radiotherapy to the reconstruction site or chest wall\n* Active abscess or infection in the intended reconstruction site\n* Residual gross tumor at the intended reconstruction site\n* Active use of any tobacco\u002Fnicotine products\n* Has body mass index (BMI) \\>35\n* Uncontrolled diabetes defined as HbA1c ≥7 within 3 months prior to stage 1 procedure\n* Is currently taking medications including systemic steroids",true,"FEMALE","22 Years",{"count":19,"type":20},467,"ESTIMATED","INTERVENTIONAL",[23],"NA","Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.",[26],"Breast Reconstruction","RECRUITING","2026-04-29",{"date":30,"type":31},"2026-04-30","ACTUAL",{"date":33,"type":31},"2024-11-22",{"date":35,"type":20},"2027-12",{"name":37,"class":38},"RTI Surgical","INDUSTRY",13,""]